National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

RecruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Adverse Drug Reaction (ADR)
Trial Locations (1)

V6H 3V4

RECRUITING

Children's and Women's Health Centre of British Columbia, Vancouver

All Listed Sponsors
collaborator

Genome Canada

OTHER

collaborator

Genome British Columbia

INDUSTRY

collaborator

Child and Family Research Institute

OTHER

collaborator

Western University, Canada

OTHER

collaborator

Provincial Health Services Authority

OTHER

collaborator

Health Canada

OTHER_GOV

collaborator

Canada Gene Cure

UNKNOWN

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Canadian Society of Clinical Pharmacology

UNKNOWN

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canada Foundation for Innovation

OTHER

collaborator

British Columbia Clinical Genomics Network

OTHER

lead

University of British Columbia

OTHER